logo

UK News

Share

Epilepsy-011918.jpg Rare commodities are worth more than good is a Chinese adage. And more so when it is in the field of medicine.

UKRetailSales-011918.jpg UK retail sales in December declined more-than-expected from the previous month when consumers were lured by Black Friday promotions, data from the Office for National Statistics revealed Friday. Retail sales volume dropped by a more-than-expected 1.5 percent from November, when they grew 1 percent. This was the biggest fall since June 2016 and the largest in seven years for the month of December.

sharemixed2-011818.jpg European stocks extended gains from the previous session on Friday as optimism about economic growth and corporate earnings helped investors shrug off concerns about a potential U.S. government shutdown. The U.S. House of Representatives passed a stop-gap funding measure late Thursday to avert a government...

shareslow-011918.jpg European stocks are seen opening a tad lower on Friday as the threat of a U.S. federal government shutdown looms. The U.S. House of Representatives passed a stop-gap funding measure late Thursday to avert a government shutdown. But prospects appear gloomy in the Senate, where Democrats say they...

Jan18-up-011818.jpg The following are some of today's top gainers in the pharma/biotech sector.

sharemixed2-011818.jpg European stocks were mixed in cautious trade on Thursday. While stronger-than-expected Chinese GDP data and expectations for improved corporate earnings supported underlying sentiment, U.K. stocks extended losses from the previous session, hit by a rising pound and mixed earnings updates. The Chinese...

stockhigh-011818.jpg European stocks may open on a positive note Thursday as investors bet on increased economic growth and improved corporate earnings. Asian stocks are trading mixed ahead of a raft of Chinese data due later in the day. Official data released earlier in the day showed that China's property market remained...

Pharma-011818.jpg Today's Daily Dose brings you news about Aeterna's alliance with Strongbridge; a new study about CellMax-CRC Colorectal Cancer Screening test and Novartis' Kymriah getting priority review from the FDA for a second indication.

Jan17-up-011718.jpg The following are some of today's top gainers in the pharma/biotech sector.

sharedrops-011718.jpg European stocks fell on Wednesday, with disappointing earnings updates, uncertainty over the shape of the government in Germany and a looming government shutdown in the U.S. keeping investors worried on a light day on the economic front. The euro paused after having rallied to more than three year...

Pharma-011718.jpg Today's Daily Dose brings you news about Juno's suitor; Eiger's failed LIBERTY trial; encouraging hepatocellular carcinoma trial data of Ipsen and Exelixis; MiMedx's progress in recalcitrant plantar fasciitis pain trial; positive FDA feedback related to the design of Athenex's breast cancer trial and MabVax's clinical trial catalysts to watch out for this quarter.

shareslower-011718.jpg European stocks may open lower on Wednesday following declines in U.S. counterparts overnight as investors await progress on talks to prevent a U.S. government shutdown this weekend. Congress needs to pass a spending bill by the end of Friday to avoid a government shutdown. A point of contention between...

Pharma-011518.jpg The following are some of today's top gainers in the pharma/biotech sector.

carillionplc-011618.jpg The UK government on Tuesday ordered a fast-track investigation into directors at the failed construction company Carillion. Carillion on Monday collapsed into liquidation after struggling with huge debt and heavy losses on contracts. The company's liquidation, which managed hundreds of public sector...

Inflation-UK-011618.jpg UK inflation slowed for the first time in six months in December, on air fares and recreational goods costs, official data showed Tuesday. Inflation eased to 3 percent in December from 3.1 percent in November, the Office for National Statistics reported. The rate came in line with expectations and was the first decrease in six months.

Follow RTT